Topical Tacrolimus as Adjuvant Therapy to Corticosteroids in Acute Endothelial Graft Rejection After Penetrating Keratoplasty: A Randomized Controlled Trial

PURPOSE:To evaluate the efficacy of topical tacrolimus 0.05% as adjuvant therapy to corticosteroids in the treatment of acute endothelial rejection of a penetrating keratoplasty (PKP) graft. METHODS:Patients with the clinical diagnosis of acute endothelial rejection of a PKP graft were randomized in...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Cornea 2018-03, Vol.37 (3), p.307-312
Hauptverfasser:	Hashemian, Mohammad Nasser, Latifi, Golshan, Ghaffari, Reza, Ghassemi, Hamed, Ghanavati, Mehran Zarei, Mohammadi, Seyed-Farzad, Yasseri, Mehdi, Fallah Tafti, Mohammad Reza, Tafti, Zahra Fallah
Format:	Artikel
Sprache:	eng
Schlagworte:	Acute Disease Administration, Topical Adolescent Adrenal Cortex Hormones - therapeutic use Adult Aged Chemotherapy, Adjuvant Corneal Diseases - surgery Female Graft Rejection - drug therapy Humans Immunosuppressive Agents - administration & dosage Keratoplasty, Penetrating Male Middle Aged Ophthalmic Solutions - administration & dosage Prednisolone - therapeutic use Recurrence Tacrolimus - administration & dosage Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!